Brief: Evelo Biosciences Reports Q1 2021 Financial Results
29/04/2021 12:44
April 29 (Reuters) - Evelo Biosciences Inc EVLO.O :
* Q1 LOSS PER SHARE $0.55
Source text for Eikon: ID:nGNX7BjfW7
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI